Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up    |  Already a member? Sign In
Pharma IQ

Martyrs & Models: Early Returns from the AMNOG Era


Martyrs & Models: Early Returns from the AMNOG Era
Download

During the past few months, IQWiG has made several decisions public for recently reviewed drugs. For the first time, a body of evidence exists which can shed some light upon how restrictive and how timely access will be under the new AMNOG legislation regime in Germany. Some brands have been particularly fortunate, however these positive outcomes have more to do with compliance with G-BA’s requests than it has to do with whether the product is actually providing clinical benefit or not. To better understand how the future access environment in Germany will take shape, each of the brands reviewed to date has been assessed for key learnings as brand managers plan for the new Germany. A full assessment against the outcomes in England, Scotland, and France also reveals how demanding the G-BA and IQWiG are shaping up to be.

By Cyrus Chowdhury, Practice Leader, Global Market Access, Insight Strategy Advisors.

 

Have Your Say
Rate this feature and give us your feedback in the comments section below


Rate this Whitepaper: (2.3 Stars | 4 Votes)


Tags:   AMNOG | Cyrus Chowdhury | market access | global market access | IQWiG | AMNOG legislation | G-BA’s | brand managers | Germany | Germant market access



Leave this field empty
Already an IQ member? Sign in
First Name:  *
Last Name:  *
Job Title:  *
Phone:  *
E-mail:  *
Company:  *
Country:  *
State  *
User Name:  *
Password:  *
Confirm Password:  *
Which of the following best describes your area of expertise?

   Yes, I'd like to also sign up for Pharma IQ.



By clicking "Submit" you are indicating that you have read, understood and agree to e-BIM's User Agreement and Privacy Policy.

Use of this site constitutes acceptance of IQPC's Privacy Policy.

A confirmation message will be sent to the e-mail above.
Please click on the link that has been sent to your e-mail to start using your account.
Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.

You Might Also Like




Advertisement

Recent Activity